Approved Study Database
Ref. No. | Scientific Title | Principal investigator |
---|---|---|
2025.497 | Histone deacetylase 9 as a novel immunoregulator of therapy resistance in hepatocellular carcinoma. |
Prof. TONG Man 唐旻 |
2025.464 | A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease |
Dr. TAN Guangming 譚廣明 |
2025.496 | Predicting Chemotherapy Response in Advanced Pancreatic Ductal Adenocarcinoma Using Multimodal Artificial Intelligence | Prof. XIA Xianfeng |
2025.429 | Viral infections and subsequent development of acute respiratory distress syndrome and interstitial lung disease | Dr Ko Wai San Fanny |
2025.437 | Effects of a Mindfulness-based Caring program to reduce nurse stress, enhance job satisfaction and retention: A randomized controlled trial | Ms. WONG Wing Yee |
2025.442 | Associations of poverty-related housing displacement and physical inactivity with adverse cardiovascular outcomes and healthcare utilisation: investigation on territory-wide household cohort | Dr. CHAN Crystal Ying |
2025.410 | Analysis of tracking patients in secondary transportation in acute stroke patients: a survey and systematic review | Dr. IP Bonaventure Yiu Ming |
2025.414 | DISON I Study (Directly Integrated Suction and Optics System for the Treatment of Nephrolithiasis - A First-In-Human Study) | Prof. NG Chi Fai |
2025.427 | A Phase II trial on Fezolinetant for vasomotor symptoms in men receiving androgen deprivation therapy (ADT) for prostate cancer (Fez-Cap) | Prof. NG Chi Fai |
2025.419 | A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease |
Prof. MA Ching Wan 馬青雲 |
2025.418 | Effectiveness of a multi-component intervention (Physical Exercise, Cognitive Training, Social interaction) in reducing frailty among older adults in primary care: a pragmatic randomized controlled trial |
Prof. Wong Samuel Yeung-Shan 黃仰山 |
2025.433 | A prospective observational study on the effect of TREM2 H157Y variant in Alzheimer’s disease | Prof. KWOK Timothy |
2025.441 | Competing Risk Quantile Regression with Time-dependent Covariates | Dr. SIT Tony |
2025.426 | ADdiction-Related Eye Assessment and Management (ADREAM) | Dr. CHONG Kelvin Kam Lung |
2025.440 | The Influence of Pre-existing Achilles Tendinopathy Severity on Long-term Functional Outcomes After Achilles Tendon Repair Surgery | Prof. LING Samuel Ka Kin |
2025.408 | Combined treatment for long COVID: cohort study | Dr. CHONG Marc Ka Chun |
2025.396 | Effectiveness of a Multimodal Hybrid Onsite and Telecare Prehabilitation Program for Adolescent Idiopathic Scoliosis Patients Receiving Spinal Fusion Surgery: A Randomised Controlled Trial | Dr. LAU Adam Yiu Chung |
2025.407 | Effect of an internet-based dialectical behaviour therapy-informed skills training for promoting smoking cessation of smokers: A pilot randomised controlled trial | Prof. HO Long Kwan |
2025.398 | Quantifying Tremor Assessment using Data-Driven Algorithm | Ms. SUEN Wing Sze |
2025.406 | Development and Validation of SMART (Simple Mild Cognitive Impairment Risk Test): A brief screening test for mild cognitive impairment | Dr. LAM Bonnie Yin Ka |
2025.397 | The Dreamcatchers Programme – A Nurse-led Multicomponent Interventional Protocol to Improve Sleep Quality in Paediatric Oncology Patients: A Pilot Randomized Controlled Trial | Miss Mak Shuk Yan |
2025.405 | Retrospective collection of TEE image with corresponding X-ray/CT/MR images and data, for Development Next-generation AI-XR Empowered Surgical Planning and Intraoperative Guidance System via Effective Fusion of Empirical Knowledge, Human Interaction, and Machine Inference. | Prof. LEE Pui Wai |
2025.386 | A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012) | Prof. MA Brigette Buig Yue |
2025.385 | A Phase 2 Study to Assess ADX-038 in Participants With Complement-Mediated Kidney Disease |
Prof. SZETO Cheuk Chun 司徒卓俊 |
2025.423 | Examining the association between senior badminton athlete’s training routine, physical fitness, and injury incidence |
Dr. NG Johan 吳又言 |
2025.416 | Prospective Multi-Centre Randomised Controlled Trial on the Effect of Collagen Scaffold Augmentation in Achilles Tendon Rupture Repair | Dr. Ling Samuel |
2025.417 | Optimal acute adult psychiatric in-patient care in Hong Kong: a mixed-method study | Ms. CHUNG Sui Mei |
2025.431 | Mental health trajectories and influencing factors among physical trauma patients in Hong Kong: a prospective longitudinal study | Prof. HUNG Kevin Kei Ching |
2025.378 | Outcomes of patients with adrenocortical carcinoma in Hong Kong: a territory-wide study | Dr. CHEUNG Kitty Kit Ting |
2025.377 | Outcomes of patients with adrenocortical carcinoma in Hong Kong: a territory-wide study | Dr. TSANG Chiu Chi |
2025.376 | Outcomes of patients with adrenocortical carcinoma in Hong Kong: a territory-wide study | Dr. WONG I Ming |
2025.404 | Oral microbiome as a non-invasive diagnostic for early detection of colorectal neoplasia | Prof. YU Jun |
2025.403 | Integrated metabolomic and metagenomic biomarkers for early colorectal neoplasia diagnosis across diverse patient populations | Prof. YU Jun |
2025.392 | PWH Spine Registry | Dr. LAU Cyrus Tsun Kit |
2025.382 | A multicenter study on the clinicopathological and genetic features of myeloid neoplasms with isochromosome 17q | Prof. NG Margaret Heung Ling |
2025.402 | Surgical accuracy of open platform image‐based robotic‐assisted total hip arthroplasty | Prof. ONG Michael Tim Yun |
2025.371 | A Case-Control Study to Identify Risk Factors for Catheter fracture of Implanted Venous Access Port in the Oncology Department |
Ms. MAK So Shan 麥素珊 |
2025.393 | Effects of dance-based multimodal exercise programme for managing chemotherapy-induced peripheral neuropathy in patients with colorectal cancer: A randomized controlled study | Ms. LAU Ka Yan |
2025.390 | Perioperative haemostasis, Procedure-related Pain after Physiological or Pharmacological modifications of Local anaesthesia around the Eyes (P4LE) – a double-masked, split-face, active-controlled, pilot randomised clinical trial | Dr. CHONG Kelvin Kam Lung |
2025.389 | Perioperative haemostasis, Procedure-related Pain after Physiological or Pharmacological modifications of Local anaesthesia around the Eyes (P4LE) – a double-masked, split-face, active-controlled, pilot randomised clinical trial | Dr. WU Anson Chun Long |
2025.401 | Adapting the CORN Intraoperative-Acquired Pressure Injury Risk Assessment Scale to Operative Settings in Hong Kong | Dr. CHAN Dorothy NS |
2025.436 | The Effects of artificial intelligence- based chatbot "NeuroBot" for improving anxiety of patients undergoing neurovascular surgeries: a randomised controlled trial | Ms. HO Chung Man |
2025.388 | CCCG-ALL 2025 Intermediate- and high-risk B-cell acute lymphoblastic leukemia |
Prof. LI Chi Kong Chi Kong LI |
2025.400 | Surgical accuracy of open platform image‐based robotic‐assisted total knee arthroplasty across different implants: a multicentre trial | Prof. ONG Michael Tim Yun |
2025.391 | Using Radiation-free Ultrasound for Screening Scoliosis Among School Children in Hong Kong to Reduce Unnecessary X-ray Exposure | Dr. KWAN Cheuk Kin |
2025.372 | A Randomized, Double-Blind, Active-Controlled Multicenter Phase 2 Study Evaluating the Efficacy and Safety of ALG-000184 Compared with Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg-Negative Adult Subjects with Chronic Hepatitis B Virus Infection (B-SUPREME) | Prof. WONG Grace Lai Hung |
2025.370 | Understanding the disease burden and improving the long-term outcomes of childhood-onset nephrotic syndrome through big data analytics | Prof. CHAN Yu Hin |
2025.365 | A Phase 3, Multicenter, Randomized, Open-label Trial of Trastuzumab Deruxtecan in Combination with Pembrolizumab Versus Platinum-based Chemotherapy in Combination with Pembrolizumab, as First-line Therapy in Participants with Locally Advanced Unresectable or Metastatic HER2 overexpressing and PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer (DESTINY-Lung06) | Dr. LOONG Herbert Ho Fung |
2025.374 | MUSCLE-ML: Multimodal integration of muscle strength, structure by Machine Learning for Precision Rehabilitation After ACL Injury |
Prof. YUNG Patrick Shu Hang 容樹恒 |
2025.367 | Retention rate of adalimumab bio-original and biosimilars in rheumatic diseases: a real-world study from the Hong Kong Biologics Registry |
Dr. TANG Hoi San 鄧凱珊 |
Page 2 of 268.